A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians

Human Molecular Genetics

Volumn 13, Issue 19, 2004, Pages 2197-2205

  Ma, Xiaowei ^a   Bacci, Simonetta ^b   Mlynarski, Wojciech ^a   Gottardo, Lucia ^c   Soccio, Teresa ^a   Menzaghi, Claudia ^b   Iori, Elisabetta ^c   Lager, Robert A ^a,d,h   Shroff, Adhir R ^a,d   Gervino, Ernest V ^a,d   Nesto, Richard W ^a,e   Johnstone, Michael T ^a,d   Abumrad, Nada A ^f   Avogaro, Angelo ^c   Trischitta, Vincenzo ^b,g   Doria, Alessandro ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h ANNE ARUNDEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CD36 ANTIGEN; CHOLESTEROL; CYTOSINE; FATTY ACID; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; ITALY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ANTIGENS, CD36; BASE SEQUENCE; CORONARY ARTERIOSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 5444230644     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh233     Document Type: Article

References (42)

1. Febbraio, M., Hajjar, D.P. and Silverstein, R.L. (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest., 108, 785-791.
2. Abumrad, N.A., el-Maghrabi, M.R., Amri, E.Z., Lopez, E. and Grimaldi, P.A. (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem., 268, 17665-17668.
3. Tandon, N.N., Kralisz, U. and Jamieson, G.A. (1989) Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem., 264, 7576-7583.
4. Greenwalt, D.E., Lipsky, R.H., Ockenhouse, C.F., Ikeda, H., Tandon, N.N. and Jamieson, G.A. (1992) Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood, 80, 1105-1115.
5. Ibrahimi, A., Sfeir, Z., Magharaie, H., Amri, E.Z., Grimaldi, P. and Abumrad, N.A. (1996) Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc. Natl Acad. Sci. USA, 93, 2646-2651.
6. Lewis, G.F., Carpentier, A., Adeli, K. and Giacca, A. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev., 23, 201-229.
7. Hajri, T., Han, X.X., Bonen, A. and Abumrad, N.A. (2002) Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest., 109, 1381-1389.
8. Febbraio, M., Abumrad, N.A., Hajjar, D.P., Sharma, K., Cheng, W., Pearce, S.F. and Silverstein, R.L. (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem., 274, 19055-19062.
9. Goudriaan, J.R., Dahlmans, V.E., Teusink, B., Ouwens, D.M., Febbraio, M., Maassen, J.A., Romijn, J.A., Havekes, L.M. and Voshol, P.J. (2003) CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J. Lipid. Res., 44, 2270-2277.
10. Aitman, T.J., Glazier, A.M., Wallace, C.A., Cooper, L.D., Norsworthy, P.J., Wahid, F.N., Al-Majali K.M., Trembling, P.M., Mann, C.J., Shoulders, C.C. et al. (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet., 21, 76-83.
11. Pravenec, M., Landa, V., Zidek, V., Musilova, A., Kren, V., Kazdova, L., Aitman, T.J., Glazier, A.M., Ibrahimi, A., Abumrad, N.A. et al. (2001) Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet., 27 156-158.
12. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A. and Evans, R.M. (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93, 241-252.
13. Qi, N., Kazdova, L., Zidek, V., Land, V., Kren, V., Pershadsingh, H.A., Lezin, E.S., Abumrad, N.A., Pravenec, M. and Kurtz, T.W. (2002) Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone. J. Biol. Chem., 277, 48501-48507.
14. Warram, J.H., Kopczynski, J., Janka, H.U. and Krolewski, A.S. (1997) Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs. Endocrinol. Metab. Clin. North Am., 26 165-188.
15. Steinberg, D. (1997) Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem., 272, 20963-20966.
16. Endemann, G., Stanton, L.W., Madden, K.S., Bryant, C.M., White, R.T. and Protter, A.A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem., 268, 11811-11816.
17. Kashiwagi, H., Tomiyama, Y., Honda, S., Kosugi, S., Shiraga, M., Nagao, N., Sekiguchi, S., Kanayama, Y., Kurata, Y. and Matsuzawa, Y. (1995) Molecular basis of CD36 deficiency. Evidence that a 478C → T substitution (proline90 → serine) in CD36 cDNA accounts for CD36 deficiency. J. Clin. Invest., 95, 1040-1046.
18. Hirano, K., Kuwasako, T., Nakagawa-Toyama, Y., Janabi, M., Yamashita, S. and Matsuzawa, Y. (2003) Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc. Med., 13, 136-141.
19. Miyaoka, K., Kuwasako, T., Hirano, K., Nozak, S., Yamashita, S. and Matsuzawa, Y. (2001) CD36 deficiency associated with insulin resistance. Lancet, 357, 686-687.
20. Furuhashi, M., Ura, N., Nakata, T. and Shimamoto, K. (2003) Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care, 26, 471-474.
21. Kajihara, S., Hisatomi, A., Ogawa, Y., Yasutake, T., Yoshimura, T., Hara, T., Mizuta, T., Ozaki, I., Iwamoto, N. and Yamamoto, K. (2001) Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese. Clin. Chim. Acta, 314, 125-130.
22. Sato, O., Kuriki, C., Fukui, Y. and Motojima, K. (2002) Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J. Biol. Chem., 277, 15703 -15711.
23. Zhang, K., Deng, M., Chen, T., Waterman, M.S. and Sun, F. (2002) A dynamic programming algorithm for haplotype block partitioning. Proc. Natl Acad. Sci. USA, 99, 7335-7339.
24. Laws, A., Hoen, H.M., Selby, J.V., Saad, M.F., Haffner, S.M. and Howard, B.V. (1997) Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler. Thromb. Vasc. Biol., 17, 64-71.
25. Perseghin, G., Scifo, P., Pagliato, E., Battezzati, A., Benedini, S., Soldini, L., Testolin, G., Del Maschio, A. and Luzi, L. (2001) Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J. Clin. Endocrinol. Metab., 86, 3188-3196.
26. Omi, K., Ohashi, J., Patarapotikul, J., Hananantachai, H., Naka, I., Looareesuwan, S. and Tokunaga, K. (2003) CD36 polymorphism is associated with protection from cerebral malaria. Am. J. Hum. Genet. 72, 364-374.
27. Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A. and Contopoulos-Ioannidis, D.G. (2001) Replication validity of genetic association studies. Nat. Genet., 29, 306-309.
28. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. and Hirschhorn, J.N. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet., 33, 177-182.
29. Jouven, X., Charles, M.A., Desnos, M. and Ducimetiere, P. (2001) Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation, 104, 756-761.
30. Carlsson, M., Wessman, Y., Almgren, P. and Groop, L. (2000) High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 20, 1588-1594.
31. Pirro, M., Mauriege, P., Tchernof, A., Cantin, B., Dagenais, G.R., Despres, J.P. and Lamarche, B. (2002) Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis, 160, 377-384.
32. Kuniyasu, A., Ohgami, N., Hayashi, S., Miyazaki, A., Horiuchi, S. and Nakayama, H. (2003) CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett., 537, 85-90.
33. Monnier, V.M., Sell, D.R., Nagaraj, R.H., Miyata, S., Grandhee, S., Odetti, P. and Ibrahim, S.A. (1992) Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes, 41 (Suppl. 2), 36-41.
34. Tong, B., Grimes, H.L., Yang, T.Y., Bear, S.E., Qin, Z., Du, K., El-Deiry, W.S. and Tsichlis, P.N. (1998) The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol. Cell. Biol., 18, 2462-2473.
35. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
36. Crawford, D.C., Carlson, C.S., Rieder, M.J., Carrington, D.P., Yi, Q., Smith, J.D., Eberle, M.A., Kruglyak, L. and Nickerson, D.A. (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am. J Hum. Genet, 74, 610-622.
37. American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary artery disease in people with diabetes. Diabetes Care, 21, 1551-1559.
38. De Cosmo, S., Bacci, S., Piras, G.P., Cignarelli, M., Placentino, G., Margaglione, M., Colaizzo, D., Di Minno, G., Giorgino, R., Liuzzi, A. and Viberti, G.C. (1997) High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia, 40, 1191-1196.
39. Shimuzu, S., Inque, K., Tani, Y. and Yamada, H. (1978) Enzymatic microdetermination of serum free fatty acids. Anal. Biochem 98, 341-345.
40. Ellestad, M.H. (1986) Stress Testing. Principles and Practice, FA Davis, Philadelphia.
41. Abecasis, G.R. and Cookson, W.O. (2000) GOLD - graphical overview of linkage disequilibrium. Bioinformatics, 16, 182-183.
42. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.